Beech Biotech is unlocking novel biology to create breakthrough treatments for preeclampsia and other complications of pregnancy.
Beech Biotech has raised €1.6M across 1 funding round from 1 investor, most recently a Grant round in Jun 2025. Based in Vaud, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-30 | Grant | €1.6M |
| Gates Foundation |
| View deal → |
